Intervention
Gemcitabine Hydrochloride
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 24 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
24 shownRandomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast CancerNCT06255392 · 2024-06-12
RECRUITINGCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsNCT05733000 · 2023-03-08
RECRUITINGTesting the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerNCT03606967 · 2021-04-13
RECRUITINGTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])NCT04267848 · 2020-06-16
RECRUITINGTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerNCT04491942 · 2021-08-25
ACTIVE_NOT_RECRUITINGTesting the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung CancerNCT04216316 · 2021-04-14
ACTIVE_NOT_RECRUITINGTesting the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerNCT04310007 · 2020-07-13
ACTIVE_NOT_RECRUITINGRamucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)NCT03971474 · 2019-05-28
COMPLETEDDirect Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerNCT03432741 · 2018-03-27
TERMINATEDNivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerNCT03366766 · 2017-12-20
TERMINATEDMirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerNCT02996825 · 2017-10-02
COMPLETEDA Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast CancerNCT03002103 · 2016-11-23
SUSPENDEDFludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by SurgeryNCT02607423 · 2015-11-19
WITHDRAWNRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsNCT02495896 · 2015-09-03
ACTIVE_NOT_RECRUITINGBuparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsNCT01971489 · 2015-09-01
WITHDRAWNGenetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26
ACTIVE_NOT_RECRUITINGChemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672 · 2013-09-06
COMPLETEDAzacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerNCT01935947 · 2013-05-01
TERMINATEDNeoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)NCT01443078 · 2011-10-01
COMPLETEDGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerNCT00942331 · 2009-07-15
COMPLETEDChemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19
COMPLETEDCarboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast CancerNCT00470249 · 2006-07-15
TERMINATEDTipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast CancerNCT00100750 · 2005-09-01
COMPLETEDCisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00016367 · 1999-05-13
COMPLETEDCommon conditions
Stage IIIA Non-Small Cell Lung Cancer5Stage IV Lung Cancer AJCC v85Advanced Urothelial Carcinoma3Recurrent Breast Carcinoma3Recurrent Non-Small Cell Lung Carcinoma3Stage IIIB Non-Small Cell Lung Cancer3Stage IV Non-Small Cell Lung Cancer3Advanced Malignant Solid Neoplasm2Advanced Ovarian Carcinoma2Anatomic Stage IV Breast Cancer AJCC v82Lung Cancer2Lung Non-Small Cell Squamous Carcinoma2Metastatic Urothelial Carcinoma2Pancreatic Adenocarcinoma2Stage IB Lung Non-Small Cell Carcinoma AJCC v72Stage III Lung Cancer AJCC v82Stage III Ovarian Cancer AJCC v82Stage III Pancreatic Cancer2Stage IIIA Lung Cancer AJCC v82Stage IIIA Lung Non-Small Cell Cancer AJCC v72Stage IIIB Lung Cancer AJCC v82Stage IV Ovarian Cancer AJCC v82Triple-Negative Breast Carcinoma2Unresectable Urothelial Carcinoma2Adult Solid Neoplasm1
Leading sponsors
National Cancer Institute (NCI)
10
City of Hope Medical Center
1
ECOG-ACRIN Cancer Research Group
1
M.D. Anderson Cancer Center
1
Mayo Clinic
1
Memorial Sloan Kettering Cancer Center
1
Northwestern University
1
Roswell Park Cancer Institute
1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
1
SWOG Cancer Research Network
1
SynCore Biotechnology Co., Ltd.
1
University of Nebraska
1
University of Southampton
1
University of Southern California
1
Trial status mix
COMPLETED8
ACTIVE_NOT_RECRUITING5
RECRUITING4
TERMINATED4
WITHDRAWN2
SUSPENDED1
Phase mix
PHASE213
PHASE17
PHASE35
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.